281 related articles for article (PubMed ID: 28066751)
1. Killing Two Cells with One Stone: Pharmacologic BCL-2 Family Targeting for Cancer Cell Death and Immune Modulation.
Ludwig LM; Nassin ML; Hadji A; LaBelle JL
Front Pediatr; 2016; 4():135. PubMed ID: 28066751
[TBL] [Abstract][Full Text] [Related]
2. Pro-apoptotic activity of BH3-only proteins and BH3 mimetics: from theory to potential cancer therapy.
Hartman ML; Czyz M
Anticancer Agents Med Chem; 2012 Oct; 12(8):966-81. PubMed ID: 22263800
[TBL] [Abstract][Full Text] [Related]
3. Defining specificity and on-target activity of BH3-mimetics using engineered B-ALL cell lines.
Koss B; Ryan J; Budhraja A; Szarama K; Yang X; Bathina M; Cardone MH; Nikolovska-Coleska Z; Letai A; Opferman JT
Oncotarget; 2016 Mar; 7(10):11500-11. PubMed ID: 26862853
[TBL] [Abstract][Full Text] [Related]
4. Autophagy contributes to modulating the cytotoxicities of Bcl-2 homology domain-3 mimetics.
Yu L; Liu S
Semin Cancer Biol; 2013 Dec; 23(6 Pt B):553-60. PubMed ID: 24012660
[TBL] [Abstract][Full Text] [Related]
5. The novel small molecular BH3 mimetics SM3 and its regulation of cell apoptosis and autophagy.
Wang Y; Fan S; Li X; Xiaokaiti Y; Pan Y; Tie L; Li X
Biochem Biophys Res Commun; 2019 Sep; 517(1):15-22. PubMed ID: 31303271
[TBL] [Abstract][Full Text] [Related]
6. Targeting ERK1/2-bim signaling cascades by BH3-mimetic ABT-737 as an alternative therapeutic strategy for oral cancer.
Shin JA; Kim LH; Lee SJ; Jeong JH; Jung JY; Lee HN; Hong IS; Cho SD
Oncotarget; 2015 Nov; 6(34):35667-83. PubMed ID: 26447615
[TBL] [Abstract][Full Text] [Related]
7. BH3-only proteins: the death-puppeteer's wires.
Ghiotto F; Fais F; Bruno S
Cytometry A; 2010 Jan; 77(1):11-21. PubMed ID: 19899133
[TBL] [Abstract][Full Text] [Related]
8. Multifaceted anticancer activity of BH3 mimetics: Current evidence and future prospects.
Opydo-Chanek M; Gonzalo O; Marzo I
Biochem Pharmacol; 2017 Jul; 136():12-23. PubMed ID: 28288819
[TBL] [Abstract][Full Text] [Related]
9. [BH3 mimetics as a strategy to complement anticancer therapies].
Hartman MŁ; Czyż M
Postepy Hig Med Dosw (Online); 2012 Feb; 66():67-77. PubMed ID: 22371408
[TBL] [Abstract][Full Text] [Related]
10. BH3 Profiling: A Functional Assay to Measure Apoptotic Priming and Dependencies.
Fraser C; Ryan J; Sarosiek K
Methods Mol Biol; 2019; 1877():61-76. PubMed ID: 30535998
[TBL] [Abstract][Full Text] [Related]
11. Targeting intrinsic apoptosis and other forms of cell death by BH3-mimetics in glioblastoma.
Karpel-Massler G; Ishida CT; Zhang Y; Halatsch ME; Westhoff MA; Siegelin MD
Expert Opin Drug Discov; 2017 Oct; 12(10):1031-1040. PubMed ID: 28712306
[TBL] [Abstract][Full Text] [Related]
12. BCL2-Family Dysregulation in B-Cell Malignancies: From Gene Expression Regulation to a Targeted Therapy Biomarker.
Tessoulin B; Papin A; Gomez-Bougie P; Bellanger C; Amiot M; Pellat-Deceunynck C; Chiron D
Front Oncol; 2018; 8():645. PubMed ID: 30666297
[TBL] [Abstract][Full Text] [Related]
13. Therapeutic inhibition of BCL-2 and related family members.
Levy MA; Claxton DF
Expert Opin Investig Drugs; 2017 Mar; 26(3):293-301. PubMed ID: 28161988
[TBL] [Abstract][Full Text] [Related]
14. BH3-only protein BIM: An emerging target in chemotherapy.
Shukla S; Saxena S; Singh BK; Kakkar P
Eur J Cell Biol; 2017 Dec; 96(8):728-738. PubMed ID: 29100606
[TBL] [Abstract][Full Text] [Related]
15. A novel BH3 mimetic efficiently induces apoptosis in melanoma cells through direct binding to anti-apoptotic Bcl-2 family proteins, including phosphorylated Mcl-1.
Liu Y; Xie M; Song T; Sheng H; Yu X; Zhang Z
Pigment Cell Melanoma Res; 2015 Mar; 28(2):161-70. PubMed ID: 25324174
[TBL] [Abstract][Full Text] [Related]
16. Role of Bim and other Bcl-2 family members in autoimmune and degenerative diseases.
Hughes P; Bouillet P; Strasser A
Curr Dir Autoimmun; 2006; 9():74-94. PubMed ID: 16394656
[TBL] [Abstract][Full Text] [Related]
17. BH3 Mimetics for the Treatment of Prostate Cancer.
Wolf P
Front Pharmacol; 2017; 8():557. PubMed ID: 28868037
[TBL] [Abstract][Full Text] [Related]
18. The role of BH3-mimetic drugs in the treatment of pediatric hepatoblastoma.
Lieber J; Armeanu-Ebinger S; Fuchs J
Int J Mol Sci; 2015 Feb; 16(2):4190-208. PubMed ID: 25690034
[TBL] [Abstract][Full Text] [Related]
19. Binding affinity of pro-apoptotic BH3 peptides for the anti-apoptotic Mcl-1 and A1 proteins: Molecular dynamics simulations of Mcl-1 and A1 in complex with six different BH3 peptides.
Modi V; Sankararamakrishnan R
J Mol Graph Model; 2017 May; 73():115-128. PubMed ID: 28279820
[TBL] [Abstract][Full Text] [Related]
20. Small-molecule inhibitors of Bcl-2 family proteins are able to induce tumor regression in a mouse model of pre-B-cell acute lymphocytic lymphoma.
Turner BC; Eves T; Refaeli Y
DNA Cell Biol; 2008 Mar; 27(3):133-42. PubMed ID: 18163880
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
